Lida Samie

Lida Samie

Auto-generated profile, based on publicly available information

Lida Samie

Department of Oral and Maxillofacial Medicine, Faculty of Dentistry, Hamadan University of Medical Sciences, Hamadan, Iran

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 April 2023 in International Journal of Analytical Chemistry
Verified
Journal Article
Open access
PDF file
ATAmir Taherkhani
Amir Taherkhani
PKParita Khodadadi
Parita Khodadadi
LSLida Samie
Lida Samie
ZAZahra Azadian
Zahra Azadian
ZBZeynab Bayat
Zeynab Bayat
Background. Mitogen-activated protein kinase 3 (MAPK3) mediates the onset, progression, metastasis, drug resistance, and poor prognosis in various malignancies, including glioma, liver, ovarian, thyroid, lung, breast, gastric, and oral cancers. Negative regulation of MAPK3 expression using miRNAs has led to therapeutic effects in cancer. Objectives. The present study performed molecular docking and dynamics simulation to identify potential MAPK3 inhibitors from natural flavonoids, possibly leading to drug development in cancer therapy. Methods. A computational drug discovery approach was performed using the AutoDock tool to identify potential MAPK3 inhibitors from 46 plant-based flavonoids. A cross-validation study was executed using the Schrödinger Maestro docking tool. Molecular dynamics (MD) was executed to evaluate the stability of docked poses between the top-ranked compounds and the MAPK3 catalytic domain. Interactions among the most potent MAPK3 inhibitors and residues within the receptors active site were studied using the BIOVIA Discovery Studio Visualizer before and after 100ns MD simulations. Results. Kaempferol 3-rutinoside-4-glucoside, kaempferol 3-rutinoside-7-sophoroside, rutin, and vicenin-2 exhibited a magnificent binding affinity to the receptors active site. In addition, the stability of the docked poses of these compounds seemed to be stable after 45ns computer simulations. Conclusion. The present study suggests that kaempferol 3-rutinoside-4-glucoside, kaempferol 3-rutinoside-7-sophoroside, rutin, and vicenin-2 could strongly bind to the MAPK3 catalytic site and could be assigned as a potent inhibitor for MAPK3. These findings may be helpful in the treatment of various cancers. However, further validation experiments are needed.

13 January 2025 in Peptide Science
Verified
Journal Article
Closed access
ZBZeynab Bayat
Zeynab Bayat
ZMZahra Majidi
Zahra Majidi
ATAmir Taherkhani
Amir Taherkhani
LSLida Samie
Lida Samie

29 September 2024 in Avicenna Journal of Dental Research
Verified
Journal Article
Open access
PDF file
LSLida Samie
Lida Samie
FAFatemeh Ahmadi-Motamayel
Fatemeh Ahmadi-Motamayel
SBShaghayegh Barkhordar
Shaghayegh Barkhordar
ADAmin Doosti-Irani
Amin Doosti-Irani
MHMehrdad Hajiloo
Mehrdad Hajiloo
Background: Patients with end-stage renal disease are at risk of dental and periodontal problems. The aim of this study was to compare the oral health index and salivary levels of calcium, phosphorus, and urea between dialysis patients and the control group. Methods: Hemodialysis patients and a control group of outpatients referring to the hospital clinics were selected for a case-control study. Socio-demographic data and the decayed, missing, and filled teeth (DMFT) index were collected using a questionnaire and dental examination by a dentist, respectively. The calcium, phosphorus, and urea levels were measured in unstimulated saliva samples. Independent t test was used to compare the mean DMFT index, calcium, phosphorus, and urea levels between the two groups. Results: A total of 50 dialysis patients and 50 control individuals were included in the study. Compared to the control group, dialysis patients had higher mean DMFT index (mean difference [MD]: 7.7, standardized mean difference [SMD]: 0.83; P<0.001), calcium level (MD: 1.8, SMD: 1.22; P<0.001), phosphorus level (MD: 18.9, SMD: 2.3; P<0.001), and urea level (42.7, 2.81; P<0.001). Conclusion: Dialysis patients with end-stage renal disease undergoing hemodialysis had worse dental and periodontal status compared to the control group. The oral and dental health status of patients with chronic kidney disease (CKD) should be regularly evaluated and monitored.

25 October 2014 in Avicenna Journal of Dental Research
Verified
Journal Article
Open access
PDF file
SJShokoofeh Jamshidi
Shokoofeh Jamshidi
SRShahrbanou Raedi
Shahrbanou Raedi
MMMahsa Mahdian
Mahsa Mahdian
LSLida Sami
Lida Sami
Introduction: Hemangiomas are the most common benign tumor of infancy that can occur anywhere in the body. Intramuscular hemangiomas (IMH) are accounting for approximately 1% of all cases and the muscles of extremities are the most common sites. Because of scarcity and variable clinical features of these tumors, we decided to report a case of IMH in the upper lip mucosa. Case Report: The patient was a 54-year-old male that was referred to our clinic for swelling of upper lip mucosa and face asymmetry. The lesion was excised. The histological study revealed an IMH. Discussion: Surgical excision might be an effective approach in IMH of upper lip. Complete resection minimizes the relapse rate of the tumor and results in favorable cosmetic outcomes. Keywords: Hemangioma; Tumor; Muscle; Lip

1 May 2026 in Genomics & Informatics
Verified
Journal Article
Open access
PDF file
ZBZeynab Bayat
Zeynab Bayat
FMFaezeh Mahdian-Khoo
Faezeh Mahdian-Khoo
LSLida Samie
Lida Samie
ATAmir Taherkhani
Amir Taherkhani
Background and objectives: Squamous cell carcinoma antigen recognized by T-cells 3 (SART3) has emerged as a promising target for cancer immunotherapy, given its overexpression in various malignancies and low or absent expression in non-tumorous tissues. This study aimed to design rationally and in silico evaluate a multi-epitope T cell vaccine targeting SART3, incorporating a TLR4 agonist adjuvant. The vaccine’s predicted immunogenicity, physicochemical properties, structural stability, and interaction with TLR4 were comprehensively assessed. Additional assessments of cytokine-inducing potential, B-cell epitopes, and disulfide engineering opportunities were also executed. Methods: Potential T-cell epitopes from SART3 were identified using IEDB and screened for antigenicity (VaxiJen), toxicity (ToxinPred), and MHC-I/II binding affinity. Cytokine-inducing epitopes were evaluated using IL4pred, IL-10Pred, and IFNepitope servers. B-cell epitopes were predicted using ElliPro. The vaccine underwent comprehensive physicochemical, structural (I-TASSER/GalaxyRefine), molecular docking (HDOCK), molecular dynamics simulations, and disulfide engineering (Disulfide by Design 2.0) analyses. Results: The optimized 344-residue vaccine demonstrated non-allergenicity, high stability (instability index 17.16), antigenicity (Vaxijen 0.67), and solubility (SOLpro 0.96). HDOCK predicted favorable vaccine–TLR4 binding (ΔG = − 265.61 kcal/mol, confidence 91%). MD simulations confirmed complex stability. Cytokine analysis revealed the potential to induce IL-4 and IL-10. The Val80–Ala123 pair exhibited the lowest bond energy (1.16 kcal/mol), indicating the optimal geometry for disulfide bond formation. The in silico immune simulations demonstrated a robust immune response following vaccine administration. Conclusion: This rationally designed SART3-targeted multi-epitope vaccine exhibits promising in silico characteristics across immunogenicity, physicochemical, cytokine-inducing, B-cell epitope, structural, and disulfide engineering profiles, warranting experimental validation for cancer immunotherapy development.